Alhydroxiquim Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India « Previous1Next » 1 of 1